Mikhail Blagosklonny and His Beliefs in Rapamycin Medication

No one likes getting old, and that is the reason you will find many products available in the market which people use to mask their age. For a long time, the thought of eliminating the process of aging was but an unrealistic dream. Aging was associated with the buildup of random molecular damaged cells that caused the human body to decline. The process was considered irreversible. According to the theory of hyperfunction, aging is a continuation of growth driven by signaling of pathways like Target of Rapamycin (TOR). However, the TOR-Centric model states that rapalogs like rapamycin can be used in the human body as a treatment for aging which can be used to extend a healthy lifespan in humans.

Rapamycin was approved in the year 2006 not only as an ant-aging medication but one that treats all age-related diseases like the metabolic disorder, cancer, autoimmunity, and cardiovascular disease. The drug is safe and can be taken daily without one having to worry about adverse side effects. It is used to rejuvenate immunity; this means that it eliminates the hyper-immunity. In the year 2010 most of the TOR-centric models were tested and approved, but the one thing that remained unchanged was rapamycin was the one medicine that can eliminate ant-aging.

Learn more: https://www.ncbi.nlm.nih.gov/pubmed/?term=blagosklonny

One of the people who firmly hold the anti-aging belief is Mikhail Blagosklonny. He is a professor of Oncology and teaches at the Roswell Park Cancer Institute. His primary foci are cancer and aging. He studied at the First Pavlov State Medical University where he was awarded his MD in internal medicine and Ph.D. in Experimental Medicine and Cardiology. Before joining Roswell Park Cancer Institute, he worked as a senior scientist in Ordway research institute and was also the associate scientist of Medicine at New York Medical College. It was the skills and the experience he got that has made him an excellent professor. He is among the people who approved the use of rapamycin not only for cancer treatment but also to deal with old age. In the longevity research of this medication, Blagosklonny is named among those who are passionate on the use of rapamycin.

Blagosklonny has done his research on cellular, molecule, and clinical investigations to this medication. He is the one who came up with the aging hyperfunction theory. Though his primary focus is on oncology, cell psychotherapy and chemotherapeutic engineering he believes just like cancer, it is possible to control aging. He also believes that cancer is curable and this is the reason that he advocates on the use of rapamycin. Blagosklonny has written over 300 research articles, reviews, and book chapters published under his name and it is no wonder that he is known to be one of the biggest and well-respected oncology researchers in the world. He gets his motivation from his love for humanity and the vision of having a community that is disease free. Visit ResearchGate to know more about Mikhail’s latest work.

  • Up for my passion for writing, I would have loved to make more contribution in the medical journals but in the next life. I encourage others looking to try mba assignment help where I got help last month. I think I agree that looking wide is the key to winning the battle of cancer and I love the research efforts to go on.

Leave a Reply

Your email address will not be published. Required fields are marked *